Donanemab is a monoclonal antibody that the U.S. Food and Drug Administration (FDA) approved on Tuesday with the goal of slowing the progression of early-stage symptomatic Alzheimer’s disease.
Read More Donanemab, Eli Lilly’s Early Alzheimer’s Disease Treatment Approved By FDA
Federal health officials have announced the recall of several lots of aloe gel and hand sanitizer due to the presence of methanol, which poses a major risk to consumers’ health.
Read More FDA Recalls Hand Sanitizer with Methanol: Linked to Blindness and Comas
Wall Street’s main stock indexes ticked higher, with the blue-chip Dow leading gains in thin trading ahead of crucial economic data.
Read More Dow leads Wall St higher in lean trading week
FDA inspectors uncover quality control issues at Neuralink’s animal research facility.
Read More Exclusive: Musk’s Neuralink brain implant company cited by FDA over animal lab issues
The first human patient has received an implant from brain-chip startup Neuralink and is recovering well.
Read More Elon Musk’s Neuralink implants brain chip in first human
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
Read More Eli Lilly’s obesity drug now available in U.S. pharmacies